Clinical Trials Directory

Trials / Completed

CompletedNCT02783469

Genetics of Diabetes Audit and Research in Tayside Scotland (DOLORisk Dundee)

Status
Completed
Phase
Study type
Observational
Enrollment
1,915 (actual)
Sponsor
University of Dundee · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

In 1997, the global prevalence of diabetes was estimated to be 125 million and this has risen to around 400 million in 2015. In addition diabetes has a number of complications including heart disease, blindness, kidney failure and amputation. This represents a significant burden on healthcare services. Type 2 diabetes (T2D) is caused by a combination of genetic and environmental factors. The aim of GoDARTS is to recruit participants with T2D to a registry to provide a platform with which to investigate the genetics of T2D, its complications and response to treatment. This study will investigate the genetic basis of diabetic neuropathic pain.

Detailed description

GoDARTS is the genetics arm of the DARTS study, which was set up to identify all diabetes patients in the Tayside region. Its aim is to improve diabetes care over and above existing practices. Participants are invited to attend to provide blood samples for DNA/RNA analysis, provide baseline anthropometric, biochemical, blood pressure and heart rate measurements as well as completing a lifestyle questionnaire containing smoking, menopausal and physical activity items. Consent is also obtained to allow anonymous linkage to electronic medical records (EMR) through use of the Community Health Index (CHI) number, a unique patient identifier that is issued to everyone registered with a general practitioner in Scotland. GoDARTS is the first EMR linked cohort in the world and provides access to individual participant longitudinal data including biochemical, comorbidity and prescription records. These are live databases and are constantly being updated. This allows for the study of genetic factors influencing T2D, its comorbidities and response to therapy. Consent has also been obtained for re-contact by collaborators, allowing for further studies of related phenotypes to take place. One of these studies is DOLORisk Dundee which aims to identify genetic and environmental risk factors for neuropathic pain.

Conditions

Interventions

TypeNameDescription
GENETICIdentification of genetic causes of diabetic neuropathic pain

Timeline

Start date
2004-10-01
Primary completion
2009-05-31
Completion
2009-05-31
First posted
2016-05-26
Last updated
2021-07-16
Results posted
2021-07-15

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT02783469. Inclusion in this directory is not an endorsement.